안압 하강 증강제
본 발명은 장기투여에 의해 작용이 감쇠되지 않고, 안정된 안압 하강 효과를 나타내는 녹내장 혹은 고안압증의 예방 또는 치료를 위한 장기 연속 투여가 가능하는 약제에 관한 것이다. The present invention pertains to a drug available for long-term continuous administration for preventing or treating glaucoma or ocular hypertension, said drug showing no decrease in efficacy during...
Saved in:
Main Authors | , , |
---|---|
Format | Patent |
Language | Korean |
Published |
02.05.2018
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | 본 발명은 장기투여에 의해 작용이 감쇠되지 않고, 안정된 안압 하강 효과를 나타내는 녹내장 혹은 고안압증의 예방 또는 치료를 위한 장기 연속 투여가 가능하는 약제에 관한 것이다.
The present invention pertains to a drug available for long-term continuous administration for preventing or treating glaucoma or ocular hypertension, said drug showing no decrease in efficacy during long-term administration and exhibiting a stable ocular hypotensive effect. The present invention pertains to a therapeutic agent for glaucoma or ocular hypertension that is to be continuously administered for a long period of time, said drug comprising an Rho kinase inhibitor, more specifically, to a therapeutic agent comprising an Rho kinase inhibitor for treating glaucoma or ocular hypertension in a patient suffering from glaucoma or ocular hypertension who has been administered with a therapeutic agent comprising the Rho kinase inhibitor for treating glaucoma or ocular hypertension continuously over a definite period of time and needs a further enhanced ocular hypotensive effect. |
---|---|
Bibliography: | Application Number: KR20177037516 |